Objective: Coronary microcirculation plays an important role in the progression of cardiac remodeling. Among angiogenic factors, it has been reported that angiotensin II may contribute to neovascularization. However, it is unknown whether inhibition of the renin-angiotensin system suppresses angiogenesis, especially within the heart. Our aim was to evaluate the effects of the angiotensinconverting enzyme inhibitor enalapril and the angiotensin II receptor type I blocker valsartan on cardiac microvasculature, function, vascular endothelial growth factor (VEGF) expression, and survival in cardiomyopathic hamsters. Methods: Male cardiomyopathic hamsters (BIO TO2) were administered either a placebo (group C), enalapril (30 mg / kg / day) (group E), or valsartan (40 mg / kg / day) (group V), starting at the age of 6 weeks. This continued until death. Hemodynamic study, histological analysis, and northern blot analysis were performed at 39 weeks. Results: Group V showed significant increases in percent fibrosis, end diastolic pressure, and LV dP/dt min, and significant decreases in percent fractional shortening, LV dP/dt max, capillary density, and the level of mRNA expression of VEGF compared with group C. Group E showed significant increases in percent fractional shortening while the capillary density and level of mRNA expression of VEGF were unchanged. The 300-day survival rate was significantly lower in group V (25.0%) but higher in group E (100%) than that of group C (66.7%). Conclusions: Therapy with valsartan may have adverse effects on survival rate concomitant with the progression of cardiac remodeling owing to impaired VEGF-mediated angiogenesis. Therapy with enalapril has a neutral effect on VEGF-mediated angiogenesis, leading to the suppression of cardiac remodeling and an increase in life expectancy.  2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
. Introduction
converting enzyme inhibitor; AII, angiotensin II; ARB, angiotensin type I receptor blockade; AST, asparaginate amino transferase; ATI receptor, angiotensin type I receptor; BK, bradykinin; BW, body weight; Cr, Heart failure develops in a stepwise fashion owing to a creatinine; DAB, 39,39-diaminobenzidine; GAPDH, glyceraldehyde-3-progressive remodeling process. Remodeled myocardium phosphate dehydrogenase; GSA-B4, the lectin Griffonia simplicifolia; is involved in cardiac hypertrophy, fibroblast proliferation, HR, heart rate; LV, left ventricular; LV dP/dt max, the maximum rate of and extracellular matrix production, leading to the progress rise in left ventricular pressure; LV dP/dt min, the maximum rate of fall of heart failure. Moreover, interstitial fibrosis may increase in capillary density, thickening of the arteriole walls, and angiography, and 10 animals were sacrificed at 273 days of inadequate angiogenesis are involved in the pathogenesis age for hemodynamic study, histological analysis, and of various forms of heart disease. Myocardial neovascuNorthern blot analysis. To examine the effects on survival, larization is an important physiological process that frethe remaining animals (12 / group) were carefully moniquently occurs in chronic myocardial ischemia. In the tored, and deaths were confirmed every day. The inacute phase of ischemia, irreversible myocyte necrosis vestigation conforms with the Guide for the Care and Use might cause failure of angiogenesis to compensate. In fact, of Laboratory Animals published by the US National significant collateralization has been demonstrated together Institutes of Health (NIH Publication No.85-23, revised with reduction in the size of the infarct after intracoronary 1996). Because there were no significant differences in administration of growth factors [1] . On the other hand, mRNA expression for VEGF or collagen I, capillary vascular endothelial growth factor (VEGF) knockout mice density, percent fibrosis, or cardiac function in F1B have impaired angiogenesis, leading to ischemic caruntreated control hamsters at the ages of 5, 13, and 20 diomyopathy [2], suggesting that VEGF is a key molecule weeks, and percent fractional shortening (%FS) and left regulating the balance between cardiac oxygen consumpventricular end-diastolic dimension (LVDd) in F1B contion and vascular growth. The angiogenic cytokines may trols treated with ACEI or ARB were similar to those in thus play a pivotal role in the progression of cardiac untreated F1B controls in the previous study [7] , F1B remodeling.
control hamsters were administered neither enalapril nor It is well known that cardiac remodeling is accompanied valsartan in this study. by local and systemic activation of the renin-angiotensin Enalapril was selected because of its general usage in system (RAS). Among the neovascularization factors, heart failure. We had previously performed two experiangiotensin II (AII), the main effecter peptide of the RAS ments using cardiomyopathic hamsters, in which enalapril may contribute to vessel growth regulation. The pro-anwas used at two different doses, 20 and 25 mg / kg / day. giogenic action of AII is mediated by the angiotensin type Each experiment gave almost the same results macro-and I receptor (AT1 receptor) through sustained activation of microscopically. Fibrosis was suppressed and cardiac VEGF production within the ischemia [3] . The effects of functions were preserved at the same levels. Serum angiotensin-converting enzyme inhibitor (ACEI) and AT1
concentrations of enalapril were measured in each group receptor blockade (ARB) of failing myocardium on excluand found to be sufficient by comparing them with clinical sively VEGF-mediated angiogenesis have not been elucidata provided by Merck (Whitehouse Station, NJ, USA) dated. Because AII formation is suppressed by ACEI and (data not shown). blocked by ARB, it is likely that ACEI and ARB inhibit
Valsartan was selected because of its higher selectivity angiogenesis. However, there are several controversial for angiotensin type 1 receptors. We considered that reports regarding the effects of ACEI and ARB on valsartan had the possibility to be more effective for heart angiogenesis. For example, an ACEI, perindopril, can failure than other ARBs. It was very difficult to decide the improve impaired angiogenesis in the ischemic limbs of dosages of valsartan suitable for this model. The bioavailspontaneous hypertensive rats [4] . Likewise, an ARB, ability of valsartan to the cardiomyopathic hamster was not losartan, improves coronary angiogenesis in infarcted known. We used valsartan at 40 mg / kg / day. No adverse hearts [5] . In contrast, ramipril and losartan impair reparaeffect was observed, and the maximum hypotensive effects tive angiogenesis in a murine model of limb ischemia [6] . were exhibited at the same level with this dosage as in the Thus, little is known about whether RAS inhibition has a enalapril group. We considered that this dose was adequate beneficial effect on coronary angiogenesis during the for cardiomyopathic hamsters. remodeling process.
To confirm that a sufficient dosage was actually reIn this study, we examined the effects of ACEI and ceived, serum AII levels were measured in the three ARB on VEGF-mediated angiogenesis in cardiomyopathic groups. hamster hearts.
.2. Serum biochemical analyses

. Methods
Serum asparaginate amino transferase (AST), creatinine, 2 .1. Experimental animals and protocol and AII levels were evaluated in 273-day-old hamsters (n510 / group). These laboratory tests were performed at At the age of 6 weeks, male BIO TO2 hamsters (Bio Special Reference Laboratories (SRL, Sapporo, Japan). Breeders, Fitchburg, MA, USA) were randomly assigned Serum AST levels were measured by the enzymatic to receive either enalapril (n524, 30 mg / kg / day, p.o.), method standardized by the Japan Society of Clinical valsartan (n524, 40 mg / kg / day, p.o.) or standard chow Chemistry. The serum creatinine concentration was mea-(n524). All drugs were given to hamsters orally throughsured by enzymatic methods. The serum AII level was out their life. Of the 24 hamsters in each group, two measured by radioimmunoassay methods. The serum conanimals were killed at 140 days of age for microvascular centration of enalapril was measured by radioimmunoassay methods at Drug Monitoring Service / Medical Service, irei, Tokyo, Japan) for 8 min and thoroughly rinsed in PBS Banyu Pharmaceuticals (Tokyo, Japan).
for 5 min two times. Sites of bound lectin were visualized by incubation in a 39,39-diaminobenzidine (DAB)-hydrogen peroxide substrate medium (Nichirei) for 5 min, 2 .3. Echocardiography followed by two additional rinses. To enhance the DAB reaction, the sections were rinsed with 0.05 M sodium The method for echocardiography was described previbicarbonate (pH 9.6) for 10 min and then incubated in ously [8] . Briefly, at the age of 39 weeks, each hamster DAB enhancing solution (Vector Laboratories, Burlingwas anesthetized with intraperitoneal injection of urethane ame, CA, USA) for 15 s. After counterstaining with (50 mg / 100 g of body weight) and a-chloralose (100 hematoxylin, the tissue sections were dehydrated through a mg / 100 g of body weight) and transthoracic echocardioggraded series of ethanol and xylene, placed on slides, and rams (Hitachi EUB 8000) were obtained with a 13-MHz coverslipped. With the use of a light microscope (PMlinear scanner. Urethane and a-chloralose do not have 10AK, Olympus, Japan) and a camera (C-35AD, significantly depressive effects on cardiac function, as Olympus), pictures of the sections were taken randomly in previously described [9] . M-mode echocardiograms were the subepicardial region, midventricular region, and subenrecorded and the left ventricular end-diastolic dimension docardial region. The numbers of coronary capillaries and (LVDd) and percent fractional shortening (%FS) were 2 cardiomyocytes were counted in a 11.25 mm area per determined. Pulsed-wave Doppler echocardiograms of section. mitral flow velocity obtained with the transducer at the cardiac apex were recorded.
.6. Northern blot analysis .4. Catheterization
The cDNA probes used in the present study were cDNA for hamster VEGF, collagen I, and glyceraldehyde-3-phosThe method for catheterization was described previously phate dehydrogenase (GAPDH) mRNA for internal con- [10] . A 1.4-French microtip catheter manometer (SPR-677, trol. All cDNA probes were uniformly labeled with Millar Instruments, Houston, TX, USA) with a TC-510 random primers using Klenow enzyme (Boehringer Manncontrol unit (Millar Instruments) was inserted into the left 32 heim) and [ P]dCTP (Life Science Products). Each prepaventricle. As indices of hemodynamics, the maximum rate ration of total RNA was isolated from a left ventricular of rise in left ventricular pressure (LV dP/dt max) and the tissue sample using TRIzol reagent (Gibco BRL). Twenty maximum rate of fall in left ventricular pressure (LV dP/ dt micrograms of denatured RNA was size fractioned on 2% min) were derived from the left ventricular pressure by formaldehyde 1.2-1.5% agarose gels and then transferred analysis with a computer system (MP-100WS, Biopac to a nylon membrane (Hybond-N 1, Amersham Life System, Santa Barbara, CA, USA) and the Acknowledged Science). Northern blot analysis was carried out according 2.0 program for the Macintosh (Biopac System).
to conventional methods. Each membrane was exposed at 280 8C to X-ray films (X-OMAT, Eastman Kodak) with a 2 .5. Histological examination single intensifying screen to increase exposure times and obtain signals in the linear range for densitometric analysis Previous studies have shown that histochemical staining of each mRNA species. The GAPDH mRNA diffuse with the lectin Griffonia simplicifolia (GSA-B4) is a density score, used as an internal control, has been shown sensitive and reliable method to visualize the entire to be unchanged in the BIO TO2 heart. To evaluate mRNA capillary vasculature within the skeletal and cardiac muslevels, an optical scanner (GT-9500, Seiko, Tokyo, Japan) cles of the hamster [11] . Therefore, left ventricular sections was utilized to digitize autoradiograms. The density of were stained with GSA-B4 (Sigma, St. Louis, MO, USA) autoradiogram bands in the digitized image was measured to examine the structure of the capillary bed. Hearts were with the NIH Image program. removed, dipped into OCT compound (Tissue-Tekீ, Sakura Finetechnicals, Tokyo, Japan), frozen in liquid nitrogen, and stored at 280 8C until use. Sections 8 mm 2 .7. Angiography thick were obtained from cross-sections taken at the widest part of the left ventricle by means of a cryostat. They were To visualize small intramyocardial coronary arteries, we fixed in acetone for 10 min and air-dried and placed in performed angiography using synchrotron radiation (SR) at phosphate-buffered saline (PBS) for 15 min two times.
the Japan Synchrotron Radiation Research Institute The sections were treated with 3% hydrogen peroxide in (SPring-8, Hyogo, Japan). To prepare samples for visualimethanol for 15 min at 4 8C to inhibit intrinsic peroxidase zation, we injected the contrast medium developed by activity, and washed two times for 5 min each in PBS.
Fujimoto et al.
[12] into a Langendorff heart preparation of GSA-B4 was diluted 1:100 in PBS and incubated with the BIO TO2 at physiological pressure. The heart was the tissue sections overnight at 4 8C. The slides were then chilled rapidly to 0 8C and was fixed in paraformaldehyde reacted with streptavidin conjugated to peroxidase (Nichfor 24 h at 4 8C. Then, the heart was cut cylindrically to a BIO hamsters treated with the control placebo. All dead animals showed pleural effusion, a congested liver and significantly heavier lung weights (data not shown). As shown in Table 1 , there was no significant difference diameter of 3 mm. We took photographs of the cylindrical in body weight (BW) among the three groups. However, samples with the use of SR at SPring 8. The energy of SR left ventricular (LV) to body weight ratios were sigwas 17 keV, and the exposure time was 30 s.
nificantly decreased in the enalapril group and increased in the valsartan group compared to the control group. To 2 .8. Statistical analysis examine the adverse effects of each treatment, serum creatinine levels and AST levels were examined and All values are expressed as means6S.E.M. Analysis of showed no significant difference among the three groups. variance with a subsequent Fisher's test was used to
The serum AII level was significantly decreased in the determine the significance of differences in multiple enalapril group and increased in the valsartan group comparisons. Values of P,0.05 were considered to indicompared to the control group. cate statistical significance. Tables 2 and 3 . No hamsters died during the final 3 .1. Effect of long-term treatment with enalapril and catheterization or echocardiographic study. Representative valsartan echocardiograms are shown in Fig. 2 . LVDd were higher in the valsartan group than in the enalapril group. %FS Survival curves for cardiomyopathic hamsters treated increased for the enalapril group compared with the with enalapril and valsartan are shown in Fig. 1 . The control. %FS decreased for valsartan compared with the 300-day survival rate of BIO hamsters treated with enalapcontrol and enalapril. ril (100%, 12 of 12 BIO hamsters survived) was sigDoppler-echocardiography revealed that the E wave was nificantly higher than that of BIO hamsters treated with the united with the A wave and one tall, sharp wave was control placebo (66.7%, eight of 12 BIO hamsters surobserved in the control and valsartan groups; that is, these vived). With valsartan, the rate (25%, three of 12 BIO groups had diastolic dysfunction. The tall, sharp wave was hamsters survived) was significantly lower than that of divided into two waves which were the E wave and the A wave in the enalapril group; that is, diastolic function was pressure (LVEDP) increased in the valsartan group commore improved in the enalapril group than in the control pared with the control and enalapril groups. Although and valsartan groups.
.3. LV function and hemodynamics
. Results
LV function and hemodynamics are summarized in
LVSP values were very low, control F1b as well as The indices of diastolic function and LV dimensions cardiomyopathic hamsters have low blood pressure by were influenced by heart rate and blood pressure. Hownature. LV dP/dt max was decreased and LV dP/dt min ever, these echocardiographic data were reliable because was increased in the valsartan group compared with the there were no differences in heart rate among the three control and enalapril groups despite the reduction in LVSP. groups and in blood pressure between the treatment groups. LV systolic pressure (LVSP) decreased in the 3 .4. Density of cardiomyocytes, capillary density, and treatment groups compared with the control group.
percent fibrosis There was no significant difference between LVSP in the enalapril group and the valsartan group. LV end-diastolic Histological parameters are summarized in Table 4 . The numeric density of cardiomyocytes, which represents the significant difference in the level of mRNA expression of viable myocytes per area, was more preserved from loss in VEGF between the enalapril group and the control the enalapril group than in the control group and was lower (0.3660.02 in the control group, 0.3960.02 in the enalapin the valsartan group than in the enalapril group. Capillary ril group, 0.2860.02 in the valsartan group). The level of density was significantly lower in the valsartan group than mRNA expression of collagen I was significantly higher in in the control and enalapril groups. There was no signifithe valsartan group than in the control and enalapril cant difference between the enalapril group and the control groups. The level of mRNA expression of collagen I was group. The percent of fibrosis was decreased in the significantly lower in the enalapril group than in the enalapril-treated group and increased in the valsartan group control group (0.6060.04 in the control group, 0.4660.04 more than in the control group (Fig. 3) .
in the enalapril group, 0.7460.05 in the valsartan group).
3 .5. mRNA expression 3 .6. Angiography Representative autoradiographs obtained by Northern blot analysis are shown in Fig. 4 . The levels of mRNA Representative angiograms are shown in Fig. 5 . Miexpression of VEGF were significantly lower in the crovasculature density was lower in the valsartan group valsartan group than in the control group. There was no than in the control group and the enalapril group. 
. Discussion
known to stimulate angiogenesis in the cornea in rabbits and in the chorioallantoic membrane in chick embryos Our study demonstrated that ACEI had a neutral effect [23, 24] . In clinical trials, PGE1 induces angiogenesis in on VEGF-mediated angiogenesis and effectively inhibited the failing heart; that is, it causes CD34-and von Willethe RAS, leading to inhibition of adverse cardiac remodelbrand factor-positive cells to increase [25] . NO and PG ing. In contrast, ARB had an adverse effect on VEGFcould be potent inducers of angiogenesis. Thus, we specumediated angiogenesis, leading to acceleration of cardiac lated that enalapril had a neutral effect on angiogenesis in remodeling in spite of the RAS inhibition.
this experiment, because proangiogenic effects mediated Why did these changes occur? Bastien et al. [13] by the activated B1 and B2 receptor pathways canceled out demonstrated that chronic blockade of AT1 receptors was anti-angiogenic effects associated with RAS inhibition. associated with a significant reduction in the survival of On the other hand, ARB selectively blocks the actions of cardiomyopathic hamsters. However, the mechanism of the AII mediated through AT1 receptors, yet potentially deleterious effects of ARBs in the hamster model has amplifies the effects mediated through AT2 receptors. AII remained unclear since their report. We confirmed results strongly induces angiogenesis in the microcirculation similar to theirs and revealed for the first time that the through the activation of AT1 receptor pathway, whereas, reason why ARB would be detrimental for the failing heart the stimulation of AT2 receptors mediates a growth-inhibis impaired angiogenesis.
itory response in the microvasculature in vivo and in vitro. It is controversial whether RAS inhibition suppresses LeNoble et al. [26] showed that CGP42112, acting as an angiogenesis, especially within the heart. There is in-AT2 agonist, blocked AII-induced angiogenesis in the sufficient evidence to support a direct effect of the RAS on developing chick chorioallantoic membrane. Munzenmaier endogenous angiogenic cytokines. In fact, AII has previet al. [27] showed that PD123319, an AT2 antagonist, ously been reported to induce a concentration-and timecoinfused with AII increased vessel density compared with dependent increase in VEGF expression by vascular AII infusion alone. Thus, we considered that ARB had an smooth muscle cells as well as endothelial cells [14] . The adverse effect on angiogenesis, because the anti-andiffering consequences of RAS inhibition noted for enalapgiogenic effect associated with RAS inhibition was enril versus valsartan in this study may be the result of hanced by stimulation of the AT2 receptor pathway. following factors.
Many clinical trials have demonstrated that blockade of Heart failure and cardiac remodeling are characterized the RAS with ACEI modulates adverse left ventricular by activation of the RAS and other neurohumoral systems.
remodeling and prolongs survival. The ELITE II trial ACEI not only inhibits the RAS but prevents breakdown of demonstrated that the effect of an ARB, losartan, on bradykinin (BK). BK enhances the angiogenic process mortality was comparable to that of an ACEI, captopril through the activation of the B1 receptor, which is induced [28] . However, there are several controversial reports by tissue damage via activation of transcription factor regarding the effects of ARB on heart failure. Mortality nuclear factor kB and B2 receptor pathways, which are was significantly increased in a subgroup receiving an responsible for the majority of biological effects of BK ARB, ACEI, and a beta-blocker in the Val-Heft trial [29] . [15, 16] . Morbidelli et al. [17] reported that the BK-induced Blockade of the AT1 receptor did not improve LV reneovascularization was abolished by a B1 receptor antagomodeling and function in the early myocardial adaptive nist. Furthermore, Emanueli et al. [18] found that B1 phase of mitral regurgitation [30] . The current study failed signaling is essential for developing new blood vessels, to demonstrate longer life expectancy caused by ARB and because the B1 knockout mouse exposed femoral artery improvement of cardiac function because of impaired showed a very high incidence of limb necrosis leading to angiogenesis. Thus, treatment with ARBs might promote auto-amputation compared with control mice, and local mortality and morbidity in a subset of heart failure. delivery of a B1 receptor agonist enhanced collateral BIO TO2 was an established model of progressive heart vascular growth in ischemic limbs of control mice.
failure [31] . We used BIO TO2 hamsters to examine the On the other hand, Silvestre et al. [19] showed that the effects of ACEI and ARB on VEGF-mediated angioproangiogenic effect of ACE inhibition mediated by the B2 genesis. Because of the similarity of the chymase contribureceptor pathway, for neovascularization, vessel density tions to the diseased heart, it appeared likely that different and blood flow, was impaired in ischemic hind limbs of B2 class effects of ACEI and ARB could be compared and knockout mice. Activation of B2 receptors causes vascular clarified [32] . endothelial cells to release autacoids such as nitric oxide Microvascular angiography was performed with (NO) and prostaglandins (PG) [20] .
synchrotron radiation at SPring-8, which is the largest and Noiri et al. [21] demonstrated that endogenous NO brightest third-generation facility in the world. Because the production by endothelial cells is a prerequisite for the synchrotron radiation at SPring-8 is ultrabright and highly angiogenic effects. Leibovich et al. [22] have shown that directional, we could visualize details of the microvasculaproduction of angiogenic activity is dependent on L-arture that are not discernible by conventional X-ray examiginine and NO synthase. In addition, PGE1 and PGI2 are nation. The impairment caused by administering valsartan and improvement induced by administering enalapril were ture, which may lead to improvement in both systolic and confirmed angiographically as well as pathologically. It diastolic functions. On the other hand, the therapy with seems that that the angiography detected more vessels in valsartan had adverse effects on survival rate concomitant the enalapril group compared to the control. However, with worsening of cardiac remodeling, especially an microvascular angiography is essentially a different methincrease in fibrosis and loss of myocytes owing to deod from histological evaluation. It is difficult to determine creased VEGF-mediated angiogenesis, which may lead to the quantity of the capillary density by microvascular deterioration in both systolic and diastolic functions in angiography, for microvascular angiography using cardiomyopathic hamsters. It is suggested that we should synchrotron radiation visualizes all vessels, including pay careful attention when an ARB is administered to capillary vessels (the diameter is under 10 mm), prepatients with heart failure. capillary vessels (10-100 mm), and small vessels (over 100 mm). On the other hand, the histological analysis evaluated only capillary vessels and revealed that there A cknowledgements was no significant difference in the capillary density between the enalapril group and the control group. Thus, We thank Professor F. Kajiya for his useful comments pre-capillary vessels and small vessels might have inconcerning angiography. This study was funded in part by creased in the enalapril group. However, we could not Research Grants on Cardiomyopathy from the Ministry of assess the possibility in the manuscript because we could Health and Welfare of Japan and Grant-in-Aid for Scinot distinguish pre-capillary and small vessels from capilentific Research from the Ministry of Education, Science lary vessels.
and Culture of Japan, No. 10358020. In BIO TO2, myocyte loss progresses after birth and cardiac remodeling progresses after myocyte loss. TGF-b is a pivotal molecule in cardiac remodeling associated with R eferences cardiac fibrosis and hypertrophy. We reported that the expression of TGF-b was already higher in BIO TO2 than 
